Use of Micronutrients Attenuates Cannabis and Nicotine Abuse as Evidenced From a Reversal Design: A Case Study

被引:5
作者
Harrison, Rachel [1 ]
Rucklidge, Julia J. [1 ]
Blampied, Neville [1 ]
机构
[1] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand
关键词
addiction; cannabis; micronutrients; minerals; treatment; vitamins; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; OPEN-LABEL TRIAL; DOUBLE-BLIND; PROTRACTED ABSTINENCE; MINERAL SUPPLEMENT; MOOD; MULTIVITAMIN; VITAMINS; COMPLEX; ADULTS;
D O I
10.1080/02791072.2013.785840
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Prior research shows that micronutrients, particularly amino acids, can assist individuals with substance dependence to quit various drugs of abuse, including cannabis, alcohol, and cocaine. As part of a wider investigation of the impact of micronutrients (mostly vitamins and minerals) on psychiatric symptoms, such as Attention-Deficit/Hyperactivity Disorder (ADHD), depression, and anxiety, we observed that many participants reduced or eliminated use of alcohol, cigarettes, and cannabis. One case using a single-case reversal (off-on-off-on-off) design is presented and shows not only on-off control of psychiatric symptoms as micronutrients are consumed or withdrawn, but also simultaneous on-off use of cannabis and cigarettes, despite not directly targeting this substance use as part of the treatment protocol. This case adds to a growing body of research supporting the use of micronutrients in the treatment of psychiatric symptoms and suggests it may extend to substance dependence. Micronutrients, by assisting with mood regulation and reductions in anxiety, may assist with successful cessation of drug use. Alternatively, they may directly impact on the brain reward circuitry believed to be involved in the expression of addictions, thereby providing the appropriate precursors and cofactors necessary for adequate neurotransmitter synthesis. This case should continue to stimulate researchers to consider the role of nutrients, in particular vitamins and minerals, in drug treatment programs and encourage more rigorous trials.
引用
收藏
页码:168 / 178
页数:11
相关论文
共 57 条
[1]   High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km):: relevance to genetic disease and polymorphisms [J].
Ames, BN ;
Elson-Schwab, I ;
Silver, EA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (04) :616-658
[2]  
[Anonymous], NAT HOUS SURV DRUG A
[3]  
[Anonymous], CONNERS ADULT ADHD D
[4]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[5]   Acetyl-L-carnitine in attention-deficit/hyperactivity disorder: A multi-site, placebo-controlled pilot trial [J].
Arnold, L. Eugene ;
Amato, Antonino ;
Bozzolo, Hernan ;
Hollway, Jill ;
Cook, Amy ;
Ramadan, Yaser ;
Crowl, Lindsay ;
Zhang, Dan ;
Thompson, Susan ;
Testa, Giussepe ;
Kliewer, Vernon ;
Wigal, Timothy ;
McBurnett, Keith ;
Manos, Michael .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) :791-801
[6]   Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study [J].
Arseneault, L ;
Cannon, M ;
Poulton, R ;
Murray, R ;
Caspi, A ;
Moffitt, TE .
BRITISH MEDICAL JOURNAL, 2002, 325 (7374) :1212-1213
[7]   Effect of a multivitamin and mineral supplement on infection and quality of life - A randomized, double-blind, placebo-controlled trial [J].
Barringer, TA ;
Kirk, JK ;
Santaniello, AC ;
Foley, KL ;
Michielutte, R .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (05) :365-371
[8]  
BLUM K, 1988, CURR THER RES CLIN E, V43, P1204
[9]   Overcoming qEEG Abnormalities and Reward Gene Deficits During Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2 Agonist Therapy: Part 2 [J].
Blum, Kenneth ;
Chen, Thomas J. H. ;
Morse, Siobhan ;
Giordano, John ;
Chen, Amanda Lih Chaun ;
Thompson, James ;
Allen, Cameron ;
Smolen, Andrew ;
Lubar, Joel ;
Stice, Eric ;
Downs, B. William ;
Waite, Roger L. ;
Madigan, Margaret A. ;
Kerner, Mallory ;
Fornari, Frank ;
Braverman, Eric R. .
POSTGRADUATE MEDICINE, 2010, 122 (06) :214-226
[10]  
Blum Kenneth, 2008, Neuropsychiatr Dis Treat, V4, P893